Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$0.21 - $0.39 $168,995 - $313,848
-804,739 Reduced 80.31%
197,278 $41,000
Q1 2023

May 15, 2023

BUY
$0.22 - $0.62 $271 - $765
1,234 Added 0.12%
1,002,017 $280,000
Q4 2022

Feb 14, 2023

SELL
$0.38 - $1.91 $10,534 - $52,950
-27,723 Reduced 2.7%
1,000,783 $420,000
Q3 2022

Nov 15, 2022

BUY
$1.46 - $2.38 $119,417 - $194,667
81,793 Added 8.64%
1,028,506 $1.66 Million
Q2 2022

Aug 15, 2022

BUY
$1.98 - $5.66 $1.53 Million - $4.37 Million
772,035 Added 441.98%
946,713 $1.9 Million
Q1 2022

May 16, 2022

BUY
$4.52 - $12.9 $649,876 - $1.85 Million
143,778 Added 465.3%
174,678 $935,000
Q4 2021

Feb 14, 2022

BUY
$9.01 - $14.1 $278,409 - $435,690
30,900 New
30,900 $385,000

Others Institutions Holding SNCE

About Science 37 Holdings, Inc.


  • Ticker SNCE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 116,348,000
  • Description
  • Science 37 Holdings, Inc. provides technology-based solutions to enable agile clinical trials and decentralized approaches. Its platform enables modern and digital approaches to clinical research by bringing together all parties, including the patient and trial investigators, nurses, coordinators, and sponsors to power workflows, centralize evid...
More about SNCE
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.